Navigation Links
Simple sea sponge helps scientists understand tissue rejection

Understanding why some transplant patients reject their new organs requires a working knowledge of how cells recognize and accept or reject each other. Xavier Fernndez-Busquets, an MBL researcher visiting from the University of Barcelona, has found the perfect ally in this quest: the red beard sea sponge, an Atlantic species that grows abundantly from just north of Cape Cod down to Florida.

The red beard sponge (Microciona prolifera) has a cell-to-cell recognition system that, on a basic level, is similar to that of humans but much simpler. It's also a good organism for laboratory research, since its cells and cell adhesion molecules can be isolated with simple, fast, and non-disruptive methods and studied, and because its fingerlike structures make grafting experiments relatively straightforward.

In experiments carried out on these sponges this summer, Dr. Fernndez-Busquets and his colleagues are studying the cells and molecules believed to be involved in the process of tissue rejection. By grafting together pieces of different individual sponges that will reject each other--a process that approximates what sometimes happens in human transplants--the scientists have observed that cells known as gray cells migrate to and amass at the graft site, a clear suggestion that they are involved in non-self tissue recognition and rejection. Researchers believe that gray cells may be a primitive form of our immune system's human killer cells.

Fernndez-Busquets has also been researching the role of the molecule called aggregation factor proteoglycan, which he has recently identified as another potential player in sponge tissue rejection reactions, and which is very easy to study in sponges. The human version of this molecule, which is different from the sponge version but similar in structure, is also believed to have important functions in cell-to-cell interactions, but is hard to study.

The ultimate goal of this research is to provide insights into the machinery behind human tissue rejection and immune responses in hopes of someday being able to control these processes and save lives.


Source:Marine Biological Laboratory

Related biology news :

1. Simple drug has the potential to save many lives threatened by malaria
2. Discovery Promises Simpler Therapy for Sickle Cell Disease
3. Simple explanation for complex pattern of feather development
4. Simple idea to dramatically improve dengue vaccinations
5. Simple home spit test to spot deadly pre-eclampsia
6. Marine sponge yields nanoscale secrets
7. Hidden sponges determine coral reefs nutrient cycle
8. Jumping gene helps explain immune systems abilities
9. Protein helps regulate the genes of embryonic stem cells
10. Scientists reveal the shape of a protein that helps retroviruses break into cells
11. Thai spice helps cut blood sugar swings
Post Your Comments:

(Date:11/9/2015)... , Nov. 09, 2015 ... addition of the "Global Law Enforcement ... offering. --> ) has ... Law Enforcement Biometrics Market 2015-2019" report ... and Markets ( ) has announced ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
(Date:10/29/2015)... Va. , Oct. 29, 2015 Daon, ... today that it has released a new version of ... customers in North America have ... IdentityX v4.0 also includes a FIDO UAF certified ... are already preparing to activate FIDO features. These customers ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... 30, 2015  Northwest Biotherapeutics (NASDAQ: NWBO ) ... immune therapies for solid tumor cancers, announced today that ... director, and the Company welcomes Neil Woodford,s ... recent anonymous internet report on NW Bio.  The Company,s ... Linda Powers stated, "We agree with Mr. Woodford ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... Program that includes over 2,000 technical presentations offered in symposia, oral sessions, ... and applied spectroscopy, covers a wide range of applications such as, but not ...
(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: ... adopted a stockholder rights plan (Rights Plan) in an ... loss carryforwards (NOLs) under Section 382 of the Internal ... --> PharmAthene,s use of its NOLs could be ... as defined in Section 382 of the Code. In ...
(Date:11/25/2015)... QUEBEC CITY , Nov. 25, 2015 /PRNewswire/ ... "Company"), affirms that its business and prospects remain ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB ... program to completion following review of the final ... met Phase 2 Primary Endpoint in men with ...
Breaking Biology Technology: